»ó´Ü¿©¹é
±â»ç (Àüü 12,041°Ç)
Çö´ë¾àÇ°, ¡®¾ÆÆ®¿¥Äܼ­Æ®¡¯ 2023 ¸Þ¼¼³ª ȸ¿ø ¸ðÁý
Çö´ë¾àÇ°(004310)ÀÇ »çȸ °øÇå È°µ¿ ¾ÆÆ®¿¥Äܼ­Æ®¿¡¼­ ¡®2023 ¸Þ¼¼³ªÈ¸¿ø¡¯À» ¸ðÁýÇÑ´Ù.Çö´ë¾àÇ°ÀÇ ¹®È­ °øÇå»ç¾÷ÀÎ ¾ÆÆ®¿¥Äܼ­Æ®´Â 2...
¹Úº´¿ì ±âÀÚ  |  2022-11-09 10:10
¶óÀÎ
¾Ë¸®ÄÚÁ¦¾à, ºÐ±âº¸°í¼­ (2022.09)
¹Úº´¿ì ±âÀÚ  |  2022-11-09 10:07
¶óÀÎ
¿¡ÀÌÇÁ·ÎÁ¨, ´ë½Ä¼¼Æ÷ ¸é¿ª°ü¹® ÀÌÁßÇ×ü °³¹ß
¿¡ÀÌÇÁ·ÎÁ¨ÀÌ ´ë½Ä¼¼Æ÷(Macrophage, ¸¶Å©·ÎÆÄÁö)ÀÇ ¸é¿ª°ü¹® ´Ü¹éÁúÀÎ CD47¿¡ °áÇÕÇÏ´Â Ç×ü¿Í ¾Ï¼¼Æ÷ Ç¥ÀûÇ×ü°¡ À¶ÇÕµÈ ÀÌÁßÇ×ü...
±è»ç¶û ±âÀÚ  |  2022-11-09 09:50
¶óÀÎ
¹Ù½ºÄ­¹ÙÀÌ¿ÀÁ¦¾à, ±â¾÷¼³¸íȸ(IR) °³ÃÖ
¹Úº´¿ì ±âÀÚ  |  2022-11-09 09:44
¶óÀÎ
¹ÙÀÌ¿ÀÇ÷¯½º, ¹«»óÁõÀÚ °áÁ¤
±è»ç¶û ±âÀÚ  |  2022-11-09 09:43
¶óÀÎ
HKÀ̳뿣, Áö¼Ó°¡´É°æ¿µº¸°í¼­ µî °ü·Ã»çÇ×(ÀÚÀ²°ø½Ã)
¹Úº´¿ì ±âÀÚ  |  2022-11-09 09:37
¶óÀÎ
Á¦³ëÅØ, ±â¾÷¼³¸íȸ(IR) °³ÃÖ
¹Úº´¿ì ±âÀÚ  |  2022-11-09 09:28
¶óÀÎ
ÆÊÁ¨»çÀ̾ð½º, Àü ÀÓÁ÷¿ø ´ë»ó µ¶°¨¹é½Å ¹«·á Á¢Á¾ ÁøÇà
ÆÊÁ¨»çÀ̾ð½º(004720)°¡ ¿Ã°Ü¿ï Äڷγª19¿Í µ¶°¨(ÀÎÇ÷翣ÀÚ)ÀÌ µ¿½Ã À¯ÇàÇÒ °ÍÀ¸·Î ¿ì·ÁµÇ´Â °¡¿îµ¥, Àü ÀÓÁ÷¿øÀÇ °Ç°­ °ü¸®¸¦ À§ÇØ...
±è»ç¶û ±âÀÚ  |  2022-11-09 09:25
¶óÀÎ
µ¿¾Æ¿¡½ºÆ¼, Ú¸ ´º·Îº¸ 3230¸¸ ´Þ·¯ ÅõÀÚ À¯Ä¡ ¿Ï·á
µ¿¾Æ¿¡½ºÆ¼´Â ¹Ì±¹ ´º·Îº¸ Æĸ¶½´Æ¼Äýº(NeuroBo Pharmaceuticals)°¡ 3230¸¸ ´Þ·¯ ±Ô¸ðÀÇ ÅõÀÚ À¯Ä¡¸¦ ¿Ï·áÇß´Ù°í 9ÀÏ...
¹Úº´¿ì ±âÀÚ  |  2022-11-09 08:03
¶óÀÎ
ÆĹ̼¿, ¶°¿À¸£´Â »ûº°
¼ºÀåÇÏ´Â ´ºÅ¬·¹¿À½Ãµå±Û·Î¹ú ´ºÅ¬·¹¿À½Ãµå MS 80% ÀÌ»óÂ÷Áö, COVID-19 mRNA ¹é½Å »ó¿ëÈ­ ÀÌÈÄ¿¡ ´Ã¾î³ª´Â RNA ±â¹Ý Ä¡·áÁ¦...
¹Úº´¿ì ±âÀÚ  |  2022-11-09 07:54
¶óÀÎ
¿¡½ºÆ¼ÆÊ, Á¶±Ý ¸Ö¾îÁø ¹Ì·¡
3Q22 Review¸ÅÃâ¾× 608¾ï¿ø(YoY+31.4%, QoQ+19.0%), ¿µ¾÷ÀÌÀÍ 45¾ï¿ø(YoY-41.6%, QoQ+28.5%)...
¹Úº´¿ì ±âÀÚ  |  2022-11-09 07:47
¶óÀÎ
¹ÙÀ̳ؽº, Àüü ¸ÅÃâ¾× 55% 748¾ï¿ø ±Ô¸ð »ý»êÁß´Ü Ã³ºÐ
¹ÙÀ̳ؽº(053030)´Â ºÎ»êÁö¹æ½ÄÇ°ÀǾàÇ°¾ÈÀüûÀ¸·ÎºÎÅÍ ºÎ»ê°øÀåÀÌ ¾à»ç¹ý À§¹ÝÀ¸·Î ÇÕ¼ºÀǾàÇ° Á¦Á¶¾÷¹« Á¤Áö óºÐÀ» ¹Þ¾Æ ¾à 747¾ï9,...
¹Úº´¿ì ±âÀÚ  |  2022-11-08 19:32
¶óÀÎ
¹ÙÀ̳ؽº, »ý»êÁß´Ü
¹Úº´¿ì ±âÀÚ  |  2022-11-08 19:18
¶óÀÎ
Ŭ¸³½ººñ¿£¾¾¢ß - 2022 4IR Awards ¹ÙÀÌ¿ÀÇコºÎ¹® ¼ö»ó
Ŭ¸³½ººñ¿£¾¾¢ß (´ëÇ¥ÀÌ»ç ÁöÁØȯ)´Â Áö³­ 3ÀÏ(¸ñ) ¼­¿ï Áß±¸ Çѱ¹ÇÁ·¹½º¼¾ÅÍ¿¡¼­ ¿­¸° ¸Ó´ÏÅõµ¥ÀÌ ÁÖÃÖ ¡®2022 Á¦6ȸ 4IR ¾î¿öÁî(...
¹Úº´¿ì ±âÀÚ  |  2022-11-08 17:22
¶óÀÎ
ÆĹ̼¿, 3ºÐ±â ´©Àû ¸ÅÃâ 483¾ï¡¦Àü³âºñ 23.4% Áõ°¡-¿µ¾÷ÀÍ 18%¡è
ÆĹ̼¿Àº 3ºÐ±â ¸ÅÃâ¾×ÀÌ 173¾ï¿øÀ¸·Î Àü³â´ëºñ 31% Áõ°¡Çß´Ù°í 8ÀÏ ¹àÇû´Ù. 3ºÐ±â±îÁö ´©Àû ¸ÅÃâ¾×Àº Áö³­ÇØ °°Àº ±â°£ ´ëºñ 23% Áõ°¡ÇÑ 483¾ï¿ø, ¿µ¾÷ÀÌÀÍÀº 18% Áõ°¡ÇÑ 97¾ï¿øÀ» ±â·ÏÇß´Ù.ÆĹ̼¿Àº ¹ÙÀÌ¿À...
±è»ç¶û ±âÀÚ  |  2022-11-08 17:20
¶óÀÎ
Å׶ó»çÀ̾ð½º, Àüȯ°¡¾×ÀÇ Á¶Á¤
¹Úº´¿ì ±âÀÚ  |  2022-11-08 17:15
¶óÀÎ
LGÈ­ÇÐ, Åëdzġ·áÁ¦ ´Ù±¹°¡ ÀÓ»ó 3»ó Áß±¹ Âü¿© Áß´Ü
LGÈ­ÇÐÀº Åëdzġ·áÁ¦ Tigulixostat (LC350189)ÀÇ ´Ù±¹°¡ ÀÓ»ó3»ó ½ÃÇè(¿¬±¸°úÁ¦¸í 'EURELIA 1 Study...
±è»ç¶û ±âÀÚ  |  2022-11-08 17:13
¶óÀÎ
LGÈ­ÇÐ, ÅõÀÚÆÇ´Ü °ü·Ã ÁÖ¿ä°æ¿µ»çÇ×
±è»ç¶û ±âÀÚ  |  2022-11-08 17:06
¶óÀÎ
¾¾Á¨, Çö±Ý¤ýÇö¹°¹è´ç °áÁ¤
±è»ç¶û ±âÀÚ  |  2022-11-08 15:48
¶óÀÎ
Æĸã½Å 'SITC 2022' Âü°¡¡¦¸é¿ªÇ×¾ÏÁ¦ µ¶¼º½ÃÇè °á°ú ¹ßÇ¥
Æĸã½Å(PharmAbcine)Àº 8ÀϺÎÅÍ 12ÀϱîÁö ¹Ì±¹ º¸½ºÅÏ¿¡¼­ °³ÃֵǴ ¹Ì±¹¸é¿ªÇ×¾ÏÇÐȸ(SITC 2022)¿¡¼­ VISTA(V-domain Ig suppressor of T cell activation) Ç×ü ¡®...
±è»ç¶û ±âÀÚ  |  2022-11-08 11:25
Back to Top